Topic: COVID’s Silver Linings: Preserving Innovation Gains in Uncertain Times
Featuring: Karen Murphy, PhD, RN, Executive Vice President and Chief Innovation Officer, and Founding Director, Steele Institute for Health Innovation at Geisinger; and Julia Strandberg, MBA, Chief Commercial Officer at Pear Therapeutics, responsible for accelerating the adoption of Prescription Digital Therapeutics.
1500: Opening remarks and introduction of speakers
1510-1540: Panelists’ presentations
1540-1555: Breakout rooms
1555-1625: Q&A with panelists
1655-1700: Closing remarks
Time: November 5, 2020 03:00 pm in Eastern Time (US and Canada)